CSTL
Castle Biosciences Inc
Price:  
20.52 
USD
Volume:  
605,750.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CSTL WACC - Weighted Average Cost of Capital

The WACC of Castle Biosciences Inc (CSTL) is 6.9%.

The Cost of Equity of Castle Biosciences Inc (CSTL) is 6.90%.
The Cost of Debt of Castle Biosciences Inc (CSTL) is 4.50%.

Range Selected
Cost of equity 5.80% - 8.00% 6.90%
Tax rate 2.00% - 7.70% 4.85%
Cost of debt 4.50% - 4.50% 4.50%
WACC 5.8% - 8.0% 6.9%
WACC

CSTL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.43 0.57
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.80% 8.00%
Tax rate 2.00% 7.70%
Debt/Equity ratio 0.02 0.02
Cost of debt 4.50% 4.50%
After-tax WACC 5.8% 8.0%
Selected WACC 6.9%